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patients (mean age 29 :±: 9 years) with rheumatic mitral stenosis
through the transarterial approach in a manner different from that
used by Babic et al. (3). Percutaneously through the right femoral
artery I) an 8F Sones catheter was introduced into the left atrium;
2) through the Sones catheter a long guide wire also was introduced
into the left atrium; 3) the Sones catheter was removed and the
long guide wire was maintained in the left atrium; 4) through this
long guide wire a balloon catheter was placed within the mitral
valve and inflated several times for about 10 to 15 s each. We
used only one balloon per procedure (diameter range 15 to 25
mm). In the last case, two long guide wires were introduced into
the left atrium but the second balloon could not loop through the
apex of the left ventricle to reach the mitral valve. Mean pulmonary
artery pressure decreased from 35.8 :±: II to 24 :±: 9 mm Hg and
the mitral valve gradient from 19 :±: 8.5 to 9.5 :±: 4.7 mm Hg.
At the same session we performed in one patient a tricuspid val-
vuloplasty and in another patient we performed tricuspid and aortic
valvuloplasty. Although a potential complication in this approach,
improper positioning of the balloon catheter through the mitral
tendineae chordae was not observed in these nine cases. No sig-
nificant mitral regurgitation was observed after the procedure.
One advantage of the transarterial approach is that it avoids
transseptal punctures and a possible residual atrial septal defect.
It seems to us that the transarterial approach is an alternative to
mitral valvuloplasty, but it will be important to demonstrate the
feasibility of the double balloon technique as already demonstrated
in the transseptal approach (l ,4).
JORGE ROBERTO BUCHLER, MD, FACC
Institute "Dante Pazzanese" of Cardiology
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Sao Paulo, Brazil
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Reply
Buchler and associates are to be complimented on their success in
using an alternative transarterial approach to balloon mitral val-
vuloplasty. Their work supplements the previous reports from Ba-
bic et al. on a retrograde approach to dilate the mitral valve. In
selected patients in whom surgical intervention is deferred and in
whom a retrograde transseptal approach to balloon valvuloplasty
is impossible, this technique may serve as a useful alternative.
Several major limitations of a retrograde transarterial approach
to the mitral valve need to be discussed, however. The first, as
noted by Buchler, concerns crossing the mitral valve retrograde
with a guide wire. In particular, improper positioning of this guide
wire through the mitral chordae could subsequently lead to im-
proper positioning of a mitral valvuloplasty balloon that could
result in chordal rupture and massive mitral regurgitation. The
anterograde technique described in our study attempts to avoid this
problem by crossing the mitral valve from the left atrial side with
a balloon-tipped catheter. Crossing the valve in this manner with
an inflated balloon minimizes the chance that subsequent guide
wire placement will be between mitral chordae.
A second technical factor that needs to be addressed concerns
the percutaneous arterial insertion of large valvuloplasty balloons,
ranging from 15 to 25 mm in outer diameter. At present, the use
of these balloons requires insertion of arterial sheaths 2: 12F in
size. As a result, there may be a significant incidence of damage
to the femoral artery, particularly in elderly patients in whom
valvuloplasty may be chosen as a nonsurgical alternative. A final
technical factor that needs to be mentioned concerning the trans-
arterial approach involves the stability of guide wire placement
during the performance of mitral valvuloplasty. In particular, mo-
tion of the balloon during inflation through the mitral anulus may
result in loss of guide wire positioning across the mitral valve from
the left ventricle to the left atrium. Because repositioning of the
guide wire through the mitral valve by a retrograde approach may
be time consuming, this may be a major technical limitation of
the described procedure.
Major limitations of the transseptal anterograde approach to
mitral valvuloplasty that are improved on with a transarterial ap-
proach are also mentioned by Buchler. In particular, the transar-
terial approach avoids transseptal puncture and a possible residual
atrial septal defect. There is no question that the transseptal ret-
rograde approach should be performed only by physicians who are
already skilled in performing transseptal catheterization. Without
this training, attempted mitral valvuloplasty will most certainly
result in a large incidence of myocardial perforation. With respect
to creation of an atrial septal defect, it is my feeling that this
complication is purely a result of the large diameter valvuloplasty
balloons used in the technique. Improvements in catheter designs
with decreases in deflated balloon profiles of valvuloplasty cath-
eters will, it is hoped, eliminate the incidence of atrial septal defects
in future valvuloplasty studies.
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